Company: IRadimed Corporation
Ticker: Nasdaq: IRMD
Sector: Healthcare
Investor Contact: Joe Dorame

IRadimed Corporation News

News

IRADIMED Names John McCreery Chief Operating Officer

WINTER SPRINGS, Fla., March 30, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that John McCreery has been appointed Chief Operating Officer, a new position within the Company. Mr. McCreery will have primary responsibility over the regulatory,...

IRADIMED CORPORATION to Present at 29th Annual Roth Conference

WINTER SPRINGS, Fla., March 01, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Roger Susi, President and Chief Executive Officer and Chris Scott, Chief Financial Officer, will present at the 29th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi...

IRADIMED CORPORATION Announces Fourth Quarter 2016 Financial Results

Reports fourth quarter 2016 revenue of $6.0 millionReports fourth quarter 2016 GAAP diluted EPS of $0.10 and non-GAAP diluted EPS of $0.11 WINTER SPRINGS, Fla., Feb. 06, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), the only known provider of non-magnetic intravenous...

IRADIMED CORPORATION Announces Third Quarter 2016 Financial Results

Reports third quarter revenue of $7.7 millionReports third quarter GAAP diluted earnings per share of $0.13 and non-GAAP of $0.14 WINTER SPRINGS, Fla., Oct. 28, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD), the only known provider of non-magnetic intravenous (IV)...

Skip to content